ID: ALA4793572

Max Phase: Preclinical

Molecular Formula: C87H109Cl2N37O18

Molecular Weight: 1959.05

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1cn(C)c(C(=O)Nc2cn(C)c(C(=O)Nc3cc(C(=O)Nc4cn(C)c(C(=O)NCCC(=O)Nc5cn(C)c(C(=O)Nc6cn(C)c(C(=O)NCC[C@@H](N)C(=O)Nc7cc(C(=O)Nc8cc(C(=O)NC[C@@H](O)CC(=O)Nc9cc(C(=O)Nc%10cn(C)c(C(=O)Nc%11cc(C(=O)Nc%12cc(C(=O)NCCC(=O)NCCCN(C)C)n(C)c%12)n(C)c%11)n%10)n(C)c9)n(C)c8)n(C)c7)n6)n5)n4)n(C)c3)n2)n1.Cl.Cl

Standard InChI:  InChI=1S/C87H107N37O18.2ClH/c1-45(125)94-60-39-121(12)73(102-60)86(141)111-65-44-124(15)72(107-65)85(140)100-51-30-59(118(9)38-51)81(136)108-62-41-119(10)70(104-62)83(138)92-23-19-67(128)101-61-40-122(13)74(103-61)87(142)110-64-43-120(11)69(105-64)82(137)91-21-17-53(88)75(130)96-47-28-56(116(7)34-47)78(133)98-49-27-55(114(5)36-49)77(132)93-32-52(126)31-68(129)95-46-25-58(115(6)33-46)80(135)109-63-42-123(14)71(106-63)84(139)99-50-29-57(117(8)37-50)79(134)97-48-26-54(113(4)35-48)76(131)90-22-18-66(127)89-20-16-24-112(2)3;;/h25-30,33-44,52-53,126H,16-24,31-32,88H2,1-15H3,(H,89,127)(H,90,131)(H,91,137)(H,92,138)(H,93,132)(H,94,125)(H,95,129)(H,96,130)(H,97,134)(H,98,133)(H,99,139)(H,100,140)(H,101,128)(H,108,136)(H,109,135)(H,110,142)(H,111,141);2*1H/t52-,53+;;/m0../s1

Standard InChI Key:  OEALSNYMNYYNMP-QQXZZZDISA-N

Associated Targets(Human)

SGC-7901 2773 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

dsDNA 365 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bel-7402 4577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MKN-45 2102 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

GISTT1 191 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1959.05Molecular Weight (Monoisotopic): 1957.8595AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Zhang M,Liang J,Jiang SK,Xu L,Wu YL,Awadasseid A,Zhao XY,Xiong XQ,Sugiyama H,Zhang W.  (2020)  Design, synthesis and anti-cancer activity of pyrrole-imidazole polyamides through target-downregulation of c-kit gene expression.,  207  [PMID:32866755] [10.1016/j.ejmech.2020.112704]

Source